Bioorganic and Medicinal Chemistry Letters p. 2846 - 2849 (2018)
Update date:2022-09-26
Topics:
Fukuda, Miwa
Sasaki, Tomomi
Hashimoto, Tomoko
Miyachi, Hiroyuki
Waki, Minoru
Asai, Akira
Takikawa, Osamu
Ohno, Osamu
Matsuno, Kenji
Kynurenine is biosynthesised from tryptophan catalysed by indoleamine 2,3-dioxygenase (IDO). The abrogation of kynurenine production is considered a promising therapeutic target for immunological cancer treatment. In the course of our IDO inhibitor programme, formal cyclisation of the isothiourea moiety of the IDO inhibitor 1 afforded the 5-Cl-benzimidazole derivative 2b-6, which inhibited both recombinant human IDO (rhIDO) activity and cellular kynurenine production. Further derivatisation of 2b-6 provided the potent inhibitor of cellular kynurenine production 2i (IC50 = 0.34 μM), which unexpectedly exerted little effect on the enzymatic activity of rhIDO. Elucidation of the mechanism of action revealed that compound 2i suppresses IDO expression at the protein level by inhibiting STAT1 expression in IFN-γ-treated A431 cells. The kynurenine-production inhibitor 2i is expected to be a promising starting point for a novel approach to immunological cancer treatment.
View MoreLiaoyang hengye Chemical Co., Ltd.
Contact:86-419-5850866
Address:North Old Xiaoxiao Road,Yantai District, Dengta, Liaoyang, Liaoning, China
Taimai Sanluck Pharmaceutical Co.,Ltd
Contact:86-592-7662921
Address:8D,No.186,Huarong Road,Huli,Xiamen,China
Shenzhen Hongyuan Import & Export Co., Ltd.
Contact:0755-26407171
Address:Shenzhen Hongyuan Chemical New Materials Technology Co., Ltd.
Contact:0086-22-23410962
Address:17-201, Ningfuli, Shuishanggongyuandong road,Nankai district, Tianjin, China
Chengdu Green Young Biopharmaceutical INC
Contact:+86-28-85337952
Address:1-B-26,Tianhe Industry Park, No.1480 of Tianfu Road,Chengdu,P.R.China,610000
Doi:10.1002/1521-3765(20010518)7:10<2261::AID-CHEM2261>3.0.CO;2-F
(2001)Doi:10.1023/A:1012385703287
(2001)Doi:10.1016/j.bmcl.2004.06.025
(2004)Doi:10.1039/jr9560000484
(1956)Doi:10.1002/jlcr.1608
(2009)Doi:10.1039/P19950001381
(1995)